Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bladder Cancer
Related studies linked through entity extraction aliases.
Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Recovery Support for Bladder Cancer Patients and Caregivers
- Status
- COMPLETED
- Phase
- NA
Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression
- Status
- WITHDRAWN
- Phase
- PHASE2
Mood Disorders Bladder Cancer
- Status
- COMPLETED
- Phase
- N/A
The Registry of Oncology Outcomes Associated with Testing and Treatment
- Status
- COMPLETED
- Phase
- N/A
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy
- Status
- UNKNOWN
- Phase
- PHASE2
Nosocomial Infections During Total Prostatic Cystectomies (TPC) With Replacement Enterocystoplasty: Prophylactic Role of Urell®, Cranberry Fruit Juice Extract (Vaccicium Macrocarpon)
- Status
- TERMINATED
- Phase
- NA
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Treatment of High-risk Non-muscle Invasive Bladder Cancer With IMUNO BGC Moreau RJ as Prophylaxis
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)
- Status
- COMPLETED
- Phase
- PHASE2
Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
UroX Biomarker Bladder Cancer Study
- Status
- UNKNOWN
- Phase
- N/A
Urine-based Detection of Non-muscle Invasive Bladder
- Status
- COMPLETED
- Phase
- N/A
A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour
- Status
- UNKNOWN
- Phase
- PHASE1
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3